Quince Therapeutics Inc

NASDAQ:QNCX  
1.82
+0.04 (+2.25%)
7:52:15 PM EDT: $1.85 +0.03 (+1.65%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Quince Therapeutics Inc Stock, NASDAQ:QNCX

611 Gateway Boulevard, Suite 273, South San Francisco, California 94080
United States of America
Phone: +1.650.910.5717
Number of Employees: 32
http://quincetx.com

Description

Quince Therapeutics, Inc. is a biopharmaceutical company, which engages in the unlocking the power of a patient�s biology for the treatment of rare diseases. Its product includes EryDex, developed using their proprietary Autologous Intracellular Drug Encapsulation (AIDE) technology platform, which is a novel device combination that uses an automated process designed to encapsulate a drug into the patient�s own red blood cells. The company was founded by Casey Crawford Lynch, Stephen Dominy, and Kristen Gafric on June 20, 2012 and is headquartered in South San Francisco, CA.